Cargando…
Volume-targeted ventilation vs pressure-controlled ventilation for very low birthweight infants: a protocol of a randomized controlled trial
BACKGROUND: Mechanical ventilation (MV) is essential in the management of critically ill neonates, especially preterm infants. However, inappropriate or prolonged use of invasive MV may result in ventilator-associated lung injury. A systemic review comparing pressure control ventilation (PCV) with v...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428577/ https://www.ncbi.nlm.nih.gov/pubmed/37587501 http://dx.doi.org/10.1186/s13063-023-07564-x |
_version_ | 1785090503833812992 |
---|---|
author | Tang, Jun Gong, Lingyue Xiong, Tao Chen, Chao Tian, Ke Wang, Aoyu Huang, Yi Liu, Wenli Zhou, Rong Zhu, Jun Mu, Dezhi |
author_facet | Tang, Jun Gong, Lingyue Xiong, Tao Chen, Chao Tian, Ke Wang, Aoyu Huang, Yi Liu, Wenli Zhou, Rong Zhu, Jun Mu, Dezhi |
author_sort | Tang, Jun |
collection | PubMed |
description | BACKGROUND: Mechanical ventilation (MV) is essential in the management of critically ill neonates, especially preterm infants. However, inappropriate or prolonged use of invasive MV may result in ventilator-associated lung injury. A systemic review comparing pressure control ventilation (PCV) with volume-targeted ventilation mode (VTV) approved that VTV reduces the incidence of death or bronchopulmonary dysplasia (BPD) in neonates; however, this study did not analyze subgroups of very low birthweight (VLBW) infants. Therefore, the aim of this study was to compare the use of VTV and PCV in VLBW infants and to provide clinical evidence for reducing mortality and complications of MV in VLBW infants. METHOD: A single-center randomized controlled trial will be performed. All eligible infants will be randomized and assigned to either VTV or PCV group with 1:1 ratio using sealed envelopes. Death or BPD at 36 weeks’ postmenstrual age will be used as the primary outcome. Secondary outcomes include BPD, death, length of invasive MV, noninvasive mechanical ventilation, and oxygen use, length of hospital stay, failure of conventional MV, rate of using high-frequency oscillatory ventilation (HFOV) as rescue therapy, rate of reintubation within 48 h, and hospital expenses. DISCUSSION: Systemic review suggested that VTV decreases the incidence of death or BPD in neonates compared to PLV; however, this study did not specifically analyze subgroups of VLBW infants. We designed this single-center randomized controlled trials (RCT) to add a significant contribution regarding the benefits of VTV for VLBW patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13063-023-07564-x. |
format | Online Article Text |
id | pubmed-10428577 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-104285772023-08-17 Volume-targeted ventilation vs pressure-controlled ventilation for very low birthweight infants: a protocol of a randomized controlled trial Tang, Jun Gong, Lingyue Xiong, Tao Chen, Chao Tian, Ke Wang, Aoyu Huang, Yi Liu, Wenli Zhou, Rong Zhu, Jun Mu, Dezhi Trials Study Protocol BACKGROUND: Mechanical ventilation (MV) is essential in the management of critically ill neonates, especially preterm infants. However, inappropriate or prolonged use of invasive MV may result in ventilator-associated lung injury. A systemic review comparing pressure control ventilation (PCV) with volume-targeted ventilation mode (VTV) approved that VTV reduces the incidence of death or bronchopulmonary dysplasia (BPD) in neonates; however, this study did not analyze subgroups of very low birthweight (VLBW) infants. Therefore, the aim of this study was to compare the use of VTV and PCV in VLBW infants and to provide clinical evidence for reducing mortality and complications of MV in VLBW infants. METHOD: A single-center randomized controlled trial will be performed. All eligible infants will be randomized and assigned to either VTV or PCV group with 1:1 ratio using sealed envelopes. Death or BPD at 36 weeks’ postmenstrual age will be used as the primary outcome. Secondary outcomes include BPD, death, length of invasive MV, noninvasive mechanical ventilation, and oxygen use, length of hospital stay, failure of conventional MV, rate of using high-frequency oscillatory ventilation (HFOV) as rescue therapy, rate of reintubation within 48 h, and hospital expenses. DISCUSSION: Systemic review suggested that VTV decreases the incidence of death or BPD in neonates compared to PLV; however, this study did not specifically analyze subgroups of VLBW infants. We designed this single-center randomized controlled trials (RCT) to add a significant contribution regarding the benefits of VTV for VLBW patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13063-023-07564-x. BioMed Central 2023-08-16 /pmc/articles/PMC10428577/ /pubmed/37587501 http://dx.doi.org/10.1186/s13063-023-07564-x Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Study Protocol Tang, Jun Gong, Lingyue Xiong, Tao Chen, Chao Tian, Ke Wang, Aoyu Huang, Yi Liu, Wenli Zhou, Rong Zhu, Jun Mu, Dezhi Volume-targeted ventilation vs pressure-controlled ventilation for very low birthweight infants: a protocol of a randomized controlled trial |
title | Volume-targeted ventilation vs pressure-controlled ventilation for very low birthweight infants: a protocol of a randomized controlled trial |
title_full | Volume-targeted ventilation vs pressure-controlled ventilation for very low birthweight infants: a protocol of a randomized controlled trial |
title_fullStr | Volume-targeted ventilation vs pressure-controlled ventilation for very low birthweight infants: a protocol of a randomized controlled trial |
title_full_unstemmed | Volume-targeted ventilation vs pressure-controlled ventilation for very low birthweight infants: a protocol of a randomized controlled trial |
title_short | Volume-targeted ventilation vs pressure-controlled ventilation for very low birthweight infants: a protocol of a randomized controlled trial |
title_sort | volume-targeted ventilation vs pressure-controlled ventilation for very low birthweight infants: a protocol of a randomized controlled trial |
topic | Study Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428577/ https://www.ncbi.nlm.nih.gov/pubmed/37587501 http://dx.doi.org/10.1186/s13063-023-07564-x |
work_keys_str_mv | AT tangjun volumetargetedventilationvspressurecontrolledventilationforverylowbirthweightinfantsaprotocolofarandomizedcontrolledtrial AT gonglingyue volumetargetedventilationvspressurecontrolledventilationforverylowbirthweightinfantsaprotocolofarandomizedcontrolledtrial AT xiongtao volumetargetedventilationvspressurecontrolledventilationforverylowbirthweightinfantsaprotocolofarandomizedcontrolledtrial AT chenchao volumetargetedventilationvspressurecontrolledventilationforverylowbirthweightinfantsaprotocolofarandomizedcontrolledtrial AT tianke volumetargetedventilationvspressurecontrolledventilationforverylowbirthweightinfantsaprotocolofarandomizedcontrolledtrial AT wangaoyu volumetargetedventilationvspressurecontrolledventilationforverylowbirthweightinfantsaprotocolofarandomizedcontrolledtrial AT huangyi volumetargetedventilationvspressurecontrolledventilationforverylowbirthweightinfantsaprotocolofarandomizedcontrolledtrial AT liuwenli volumetargetedventilationvspressurecontrolledventilationforverylowbirthweightinfantsaprotocolofarandomizedcontrolledtrial AT zhourong volumetargetedventilationvspressurecontrolledventilationforverylowbirthweightinfantsaprotocolofarandomizedcontrolledtrial AT zhujun volumetargetedventilationvspressurecontrolledventilationforverylowbirthweightinfantsaprotocolofarandomizedcontrolledtrial AT mudezhi volumetargetedventilationvspressurecontrolledventilationforverylowbirthweightinfantsaprotocolofarandomizedcontrolledtrial |